Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 12, 1997, Pages 4101-4104

  Brauch, Hiltrud ^a,e   Hoeppner, Wolfgang ^a   Jähnig, Hendrik ^b   Wöhl, Thorsten ^a   Engelhardt, Dieter ^c   Spelsberg, Fritz ^d   Ritter, Michael M ^c  

^a UNIVERSITY OF HAMBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Martha und Maria Helfen Krankenhaus Munchen   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENE MUTATION; GERM LINE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0030781576     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.12.4101     Document Type: Article

References (19)

1. Neumann HPH, Berger DP, Sigmund G, et al. 1993 Pheochromocytomas, multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med. 329:1531-1538.
2. Latif F, Tory K, Gnarra J, et al. 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1317-1320.
3. Mulligan LM, Kwok JB, Healey CS, et al. 1993 Germline mutations of the ret proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363:458-460.
4. Eng C, Smith DP, Mulligan LM, et al. 1994 Point mutations within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet. 3:237-241.
5. Richards FM, Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. 1994 Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet. 3:595-598.
6. Brauch H, Kishida T, Glavac D, et al. 1995 von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region in Germany: evidence for a founder effect. Hum Genet. 4:2139-2143.
7. Chen F, Kishida T, Masahiro Y, et al. 1995 Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlation with phenotype. Hum Mutat. 5:66-75.
8. Glavac D, Neumann HPH, Wittke C, et al. 1996 Mutations in the VHL tumor suppressor gene and associated lesions with von Hippel-Lindau disease from Central Europe. Hum Genet. 98:271-280.
9. Frank-Raue K, Kratt T, Hoeppner W, Buhr H, Ziegler R, Raue F. 1996 Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene. Eur J Endocrinol. 135:222-225.
10. Eng C, Clayton D, Schuffenecker I, et al. 1996 The relationship between specific ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. JAMA. 276:1575-1579.
11. Zbar B, Kishida T, Chen F, et al. 1996 Germline mutations in the von Hippel-Lindau Disease (VHL) gene in families from North America, Europe and Japan. Hum Mutat. 8:348-357.
12. Duan DR, Pause A, Burgess WH, et al. 1995 Inhibition of transcription elongation by the VHL tumor suppressor protein. Science. 269:1402-1406.
13. Trupp M, Fainzilber M, Nilsson AS, et al. 1996 Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 381:785-789.
14. Neumann HPH, Eng C, Mulligan LM, et al. 1995 Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia type 2. JAMA. 274:1149-1151.
15. Ritter MM, Frilling A, Crossey PA, et al. 1996 Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J Clin Endocrinol Metab. 81:1035-1037.
16. Eng C, Crossey PA, Mulligan LM, et al. 1995 Mutations in the ret protooncogene and the von Hippel-Lindau disease tumor suppressor gene in sporadic and syndromic phaeochromocytomas J Med Genet. 32:934-937.
17. Beldjord C, Desclaux-Arramond F, Raffin-Sanson M, et al. 1995 The ret protooncogene in sporadic pheochromocytomas: frequent MEN 2 like mutations and new molecular defects. J Clin Endocrinol Metab. 80:2063-2068.
18. Lindor NM, Honchel R, Khosla S, Thibodeau SN. 1995 Mutations in the ret protooncogene in sporadic pheochromocytomas. J Clin Endocrinol Metab. 80:627-629.
19. Bar M, Friedman E, Jacobovitz O, et al. Sporadic pheochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes. Clin Endocrinol. In press.